Acetazolamide use in specific populations: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Acetazolamide}} {{CMG}}; {{AE}} {{SS}} ==Use in Specific Populations== ===Pregnancy: Teratogenic effects: Pregnancy Category C=== Acetazolamide, administered or...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Acetazolamide#Use in Specific Populations]]
{{Acetazolamide}}
{{CMG}}; {{AE}} {{SS}}
 
==Use in Specific Populations==
 
===Pregnancy: Teratogenic effects: Pregnancy Category C===
 
Acetazolamide, administered orally or parenterally, has been shown to be teratogenic (defects of the limbs) in mice, rats, hamsters, and rabbits. There are no adequate and well-controlled studies in pregnant women. Acetazolamide should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
 
===Nursing Mothers===
 
Because of the potential for serious adverse reactions in nursing infants from DIAMOX, a decision should be made whether to discontinue nursing or to discontinue the drug taking into account the importance of the drug to the mother. Acetazolamide should only be used by nursing women if the potential benefit justifies the potential risk to the child.
 
===Pediatric Use===
 
The safety and effectiveness of DIAMOX SEQUELS in pediatric patients below the age of 12 years have not been established. Growth retardation has been reported in children receiving long-term therapy, believed secondary to chronic acidosis.
 
===Geriatric Use===
 
Metabolic acidosis, which can be severe, may occur in the elderly with reduced renal function.
 
In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or other drug therapy.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = DIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74e47451-2bc8-496e-88ad-c10002ee8e22 | publisher =  | date =  | accessdate = 25 February 2014 }}</ref>
 
==References==
{{reflist|2}}
 
{{Anticonvulsants}}
{{Antiglaucoma preparations and miotics}}
{{Diuretics}}
 
[[Category:Carbonic anhydrase inhibitors]]
[[Category:Mountaineering and health]]
[[Category:Anticonvulsants]]
[[Category:Sulfonamides]]
[[Category:World Health Organization essential medicines]]
[[Category:Thiadiazoles]]
[[Category:Amides]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 15:16, 21 July 2014